Posted inGenetics
“CRISPR Meets GPT” to Supercharge Gene Editing
CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant…
Posted inGenetics
Profluent’s AI-Designed Gene Editor Provides Glimpse Into Generalizable Platform
Illustration of OpenCRISPR-1 [Profluent] Ali Madani, PhD, CEO of Profluent, says there’s an urgent need to move away from the…
Posted inGenetics
Early Gene Therapy Provides Lasting HIV Protection in Newborn Primates
Despite decades of progress, pediatric HIV continues to pose devastating challenges in regions with limited access to care. Globally, more…
Posted inGenetics
Decision Making AI “Scientists” Perform Sophisticated, Interdisciplinary Research
Imagine you’re a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know you…
Posted inGenetics
Ofichem Acquires Meribel Pharma Solutions’ Uppsala Site
Ofichem, a Netherlands-based CDMO, acquired Meribel Pharma Solutions’ site in Uppsala, Sweden, to support early-phase, IP-driven drug substance development and…
Posted inGenetics
Fyodor Urnov Discusses CRISPR Cures
In a keynote talk during GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11,…
Posted inGenetics
Base Editing and More
In this talk in GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11, 2025,…
Posted inGenetics
GSK, Hengrui Focus on Cancer, Respiratory Diseases, I&I in Up-to-$12.5B Collaboration
GlaxoSmithKline (GSK) will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology, and inflammation…
Posted inGenetics
Ancient DNA, Dire Wolves, and De-Extinction
In the closing keynote of GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11,…
Posted inGenetics
Gene Therapy in Africa
In the second session of GEN’s “The State of CRISPR & Genome Editing” virtual summit, originally broadcast on June 11,…